Amrize (NYSE:AMRZ) Given New $48.00 Price Target at JPMorgan Chase & Co.

Amrize (NYSE:AMRZ) had its price objective reduced by stock analysts at JPMorgan Chase & Co. from $52.00 to $48.00 in a report issued on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price would indicate a potential upside of 31.87% from the stock’s previous close.

Several other equities research analysts have also issued reports on the company. Royal Bank Of Canada decreased their target price on Amrize from $48.00 to $32.00 and set an “underperform” rating for the company in a research report on Friday. Deutsche Bank Aktiengesellschaft lowered their target price on Amrize from $64.00 to $56.00 and set a “buy” rating on the stock in a research note on Wednesday, September 23rd. Bank of America reissued an “underperform” rating and issued a $40.00 price target (down from $50.00) on shares of Amrize in a report on Wednesday, September 2nd. Sanford C. Bernstein restated an “outperform” rating and set a $60.00 price target on shares of Amrize in a research report on Monday, September 21st. Finally, Wells Fargo & Company decreased their price objective on shares of Amrize from $44.00 to $40.00 and set an “equal weight” rating for the company in a report on Monday, October 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company’s stock. According to MarketBeat.com, Amrize has a consensus rating of “Hold” and a consensus target price of $50.00.

Amrize Stock Performance

Shares of AMRZ stock traded up $0.31 during trading on Tuesday, hitting $36.40. The company’s stock had a trading volume of 1,823,987 shares, compared to its average volume of 3,354,850. The company has a market cap of $20.13 billion, a PE ratio of 16.78, a P/E/G ratio of 1.27 and a beta of 0.20. The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33. The business has a fifty day moving average of $42.03 and a 200-day moving average of $49.30. Amrize has a 52 week low of $35.78 and a 52 week high of $65.94.

Amrize (NYSE:AMRZ) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The business had revenue of $3.49 billion for the quarter. As a group, research analysts anticipate that Amrize will post 2.46 earnings per share for the current year.

Insider Buying and Selling at Amrize

In other news, insider Mario Gross bought 3,568 shares of the stock in a transaction on Tuesday, August 11th. The shares were purchased at an average cost of $46.60 per share, for a total transaction of $166,268.80. Following the completion of the purchase, the insider directly owned 38,485 shares in the company, valued at $1,793,401. This represents a 10.22% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jacques Sanche purchased 4,150 shares of the company’s stock in a transaction dated Wednesday, August 26th. The shares were purchased at an average cost of $45.02 per share, for a total transaction of $186,833.00. Following the transaction, the director directly owned 9,766 shares in the company, valued at approximately $439,665.32. The trade was a 73.90% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased 48,983 shares of company stock valued at $2,158,755 in the last quarter. Insiders own 0.54% of the company’s stock.

Institutional Investors Weigh In On Amrize

Large investors have recently added to or reduced their stakes in the company. Continuum Advisory LLC purchased a new stake in shares of Amrize in the second quarter worth about $62,000. NewEdge Advisors LLC grew its stake in Amrize by 1,419.7% during the second quarter. NewEdge Advisors LLC now owns 2,082 shares of the company’s stock valued at $111,000 after acquiring an additional 1,945 shares in the last quarter. Oslo Pensjonsforsikring AS purchased a new position in Amrize during the first quarter valued at approximately $133,000. Caldwell Sutter Capital Inc. grew its stake in Amrize by 11.5% during the first quarter. Caldwell Sutter Capital Inc. now owns 2,675 shares of the company’s stock valued at $150,000 after acquiring an additional 275 shares in the last quarter. Finally, MidFirst Bank purchased a new position in Amrize during the fourth quarter valued at approximately $187,000.

About Amrize

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim’s North American business and began operating as an independent, publicly traded company in 2025.